CClinicalTrials.gg
CompletedNCT03844308Updated Feb 2, 2021

Wellness Tool in Anesthesia Providers

An interventional study of Isha Kriya Meditation in Burnout, Professional, Occupational Stress and Affective Symptoms, sponsored by Beth Israel Deaconess Medical Center. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-02-02.

Sponsored by Beth Israel Deaconess Medical Center · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
94
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This study will examine the effects of Isha Kriya meditation on stress and burnout among healthcare providers.

Read the detailed description

In this study, investigators will evaluate the effect of Isha Kriya meditation on stress and burnout among perioperative healthcare providers. To do this, investigators will randomize healthy participants to one of two groups: one who will meditate twice daily for six weeks (group 1), and the other who will not meditate for first six weeks and then meditate for another six weeks (group 2). Investigators will then evaluate stress and burnout using validated electronic instruments at baseline and at six weeks for group 1 and at baseline, six weeks, and 12 weeks for group 2.

02

Conditions studied

  • Burnout, Professional
  • Occupational Stress
  • Affective Symptoms
03

In context

Burnout, Professional

214 studies on the registry are indexed under Burnout, Professional; 33 are open to participants now.

This study's enrollment of 94 is above the median of 80 across 158 interventional studies indexed under Burnout, Professional.

Browse Burnout, Professional studies →

Lead sponsor

Beth Israel Deaconess Medical Center is the lead sponsor of 560 studies on the registry; 80 are open to participants now.

Of its 75 completed or terminated interventional studies of FDA-regulated products, 61 (81%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Age ≥18 years
  • Perioperative healthcare provider

Exclusion criteria

Exclusion Criteria:

  • Low English proficiency
  • Currently enrolled in another interventional study that could impact the primary outcome, as determined by the Principal Investigator
  • Not currently residing in the United States
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Participant)
Enrollment
94 participants (actual)

Study arms

  • Experimental
    Group 1

    Participants will be asked to complete Isha Kriya meditation twice daily for a total of six weeks in phase 1.

    Behavioral: Isha Kriya Meditation

  • Active comparator
    Group 2

    Participants will be asked to refrain from meditating for the first 6 weeks (phase 1) and then asked to complete Isha Kriya meditation for another 6 weeks (phase 2)

    Behavioral: Isha Kriya Meditation

Interventions

  • BehavioralIsha Kriya Meditation

    Isha Kriya (IK) meditation is a meditation that can be learned quickly and requires approximately 12 minutes, twice a day practice. This regimen was chosen because it excels in simplicity and is a great way to introduce meditation to beginners. It does not incorporate a spiritual or religious focus. It was developed by the Isha Institute of Inner Sciences, a nonprofit foundation located at McMinnville, Tennessee.

06

What researchers measure

Primary outcomes

  1. Changes in burnout levels among perioperative healthcare providers

    Changes in burnout level due to meditation will be measured by Maslach Burnout Inventory (MBI)

    Time frame: From baseline to six weeks for group1 and baseline to 12 weeks for group 2

  2. Changes in stress levels among perioperative healthcare providers

    Changes in stress levels due to meditation will be measured by perceived stress scale (PSS; Scores can range from 0 to 40, with higher scores indicating higher perceived stress)

    Time frame: From baseline to six weeks for group 1 and baseline to 12 weeks for group 2

  3. Changes in mood disturbances among perioperative healthcare providers

    Changes in mood disturbances due to meditation will be measured by profile of mood survey (POMS)

    Time frame: From baseline to six weeks for group 1 and baseline to 12 weeks for group 2

Secondary outcomes

  1. Adherence to implementing a meditation program among healthcare providers.

    In this descriptive study, evaluation of feasibility will include adherence to meditation intervention (the proportion of completed meditation sessions out of the total required per protocol).

    Time frame: From baseline to six weeks for group 1 and baseline to 12 weeks for group 2

07

Study locations

1 site
  • Beth Israel Deaconess Medical Center
    Boston, Massachusetts 02215, United States
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 2, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03844308
Lead sponsor
Beth Israel Deaconess Medical Center
Responsible party
Balachundhar Subramaniam (Associate Professor of Anesthesia, Beth Israel Deaconess Medical Center) — Principal investigator
First posted
Feb 18, 2019
Start date
Jan 15, 2019
Primary completion
Oct 31, 2020
Completion
Oct 31, 2020
Last update
Feb 2, 2021

Study contacts

Balachundhar Subramaniam, MD, MPH
principal investigator · Beth Israel Deaconess Medical Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion